Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-22

Clinical Trial Update: Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing norepinephrine plus dobutamine versus epinephrine alone for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dobutamine (dobutamine)
  • EPINEPHRINE (EPINEPHRINE)
  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: University of Versailles | Conditions: Septic Shock, Severe Sepsis | Phase 2, Phase 3 | Status: COMPLETED